688758 赛分科技
已收盘 02-27 15:00:00
资讯
新帖
简况
赛分科技发布2025年度业绩快报,盈利1.264亿元
证券之星 · 02-27 17:16
赛分科技发布2025年度业绩快报,盈利1.264亿元
每周股票复盘:赛分科技(688758)两日获机构大宗交易净买入超789万元
证券之星 · 02-15
每周股票复盘:赛分科技(688758)两日获机构大宗交易净买入超789万元
2月12日赛分科技现1笔大宗交易 机构净买入395.2万元
证券之星 · 02-12
2月12日赛分科技现1笔大宗交易 机构净买入395.2万元
2月11日赛分科技现1笔大宗交易 机构净买入394.2万元
证券之星 · 02-11
2月11日赛分科技现1笔大宗交易 机构净买入394.2万元
2月10日赛分科技发布公告,股东减持101.16万股
证券之星 · 02-10
2月10日赛分科技发布公告,股东减持101.16万股
赛分科技(688758.SH):财务总监卞庆莲辞任
中金财经 · 02-10
赛分科技(688758.SH):财务总监卞庆莲辞任
每周股票复盘:赛分科技(688758)股东拟合计减持不超6%股份
证券之星 · 01-18
每周股票复盘:赛分科技(688758)股东拟合计减持不超6%股份
赛分科技(688758.SH)股东拟合计减持不超6%股份
智通财经 · 01-12
赛分科技(688758.SH)股东拟合计减持不超6%股份
赛分科技(688758)2.56亿股限售股将于1月12日解禁,占总股本61.4%
证券之星 · 01-12
赛分科技(688758)2.56亿股限售股将于1月12日解禁,占总股本61.4%
每周股票复盘:赛分科技(688758)61.40%限售股将上市流通
证券之星 · 01-02
每周股票复盘:赛分科技(688758)61.40%限售股将上市流通
赛分科技(688758)披露首次公开发行部分限售股及部分战略配售限售股上市流通公告,12月29日股价下跌1.27%
证券之星 · 2025-12-29
赛分科技(688758)披露首次公开发行部分限售股及部分战略配售限售股上市流通公告,12月29日股价下跌1.27%
12月15日赛分科技跌5.05%,广发中证A500ETF联接A基金重仓该股
证券之星 · 2025-12-15
12月15日赛分科技跌5.05%,广发中证A500ETF联接A基金重仓该股
每周股票复盘:赛分科技(688758)抗体领域收入占工业纯化六成
证券之星 · 2025-11-16
每周股票复盘:赛分科技(688758)抗体领域收入占工业纯化六成
11月13日赛分科技涨10.92%,广发中证A500ETF联接A基金重仓该股
证券之星 · 2025-11-13
11月13日赛分科技涨10.92%,广发中证A500ETF联接A基金重仓该股
【机构调研记录】同泰基金调研赛分科技
证券之星 · 2025-11-12
【机构调研记录】同泰基金调研赛分科技
【机构调研记录】交银施罗德基金调研慧翰股份、赛分科技
证券之星 · 2025-11-12
【机构调研记录】交银施罗德基金调研慧翰股份、赛分科技
【私募调研记录】天虫资本调研赛分科技
证券之星 · 2025-11-12
【私募调研记录】天虫资本调研赛分科技
【私募调研记录】信复创值调研赛分科技
证券之星 · 2025-11-12
【私募调研记录】信复创值调研赛分科技
【私募调研记录】翼虎投资调研赛分科技
证券之星 · 2025-11-12
【私募调研记录】翼虎投资调研赛分科技
【机构调研记录】民生加银基金调研赛分科技、欧陆通
证券之星 · 2025-11-10
【机构调研记录】民生加银基金调研赛分科技、欧陆通
加载更多
公司概况
公司名称:
苏州赛分科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2025-01-10
主营业务:
苏州赛分科技股份有限公司的主营业务是研发和生产用于生物大分子等药物分析检测和分离纯化的液相色谱材料。公司主要产品为分析色谱柱、分析色谱填料、层析介质、预装柱,提供从药品研发、临床前(Pre-IND)到临床Ⅰ、Ⅱ、Ⅲ期、生产以及质控全周期全流程的分离纯化产品及相关服务。公司是集研发、生产与全球销售于一体的高新技术企业,荣获国家级专精特新“小巨人”企业等荣誉称号。
发行价格:
4.32
{"stockData":{"symbol":"688758","market":"SH","secType":"STK","nameCN":"赛分科技","latestPrice":20.11,"timestamp":1772175600000,"preClose":20.6,"halted":0,"volume":3011495,"delay":0,"changeRate":-0.0238,"floatShares":298000000,"shares":416000000,"eps":0.2975,"marketStatus":"已收盘","change":-0.49,"latestTime":"02-27 15:00:00","open":20.57,"high":20.58,"low":20.11,"amount":60931600,"amplitude":0.0228,"askPrice":20.12,"askSize":212,"bidPrice":20.11,"bidSize":30,"shortable":0,"etf":0,"ttmEps":0.2975,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772415000000},"marketStatusCode":5,"adr":0,"adjPreClose":20.6,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":22.66,"lowLimit":18.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":416464084,"isCdr":false,"pbRate":6.35,"roa":"--","peRate":67.596639,"roe":"7.29%","epsLYR":0.2324,"committee":-0.308305,"marketValue":8375000000,"turnoverRate":0.0101,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-03-02。","afterMarket":{"amount":0,"volume":0,"close":20.11,"buyVolume":0,"sellVolume":200,"time":1772177637558,"indexStatus":"已收盘 02-27 15:30:00","preClose":20.6},"floatMarketCap":5996000000},"requestUrl":"/m/hq/s/688758","defaultTab":"news","newsList":[{"id":"2614835539","title":"赛分科技发布2025年度业绩快报,盈利1.264亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614835539","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614835539?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:16","pubTimestamp":1772183783,"startTime":"0","endTime":"0","summary":"证券之星消息,赛分科技近日即将发布2025年年报,根据2月27日发布的业绩快报,归属净利润盈利1.264亿元,同比增长48.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700028389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688758"],"gpt_icon":0},{"id":"2611145861","title":"每周股票复盘:赛分科技(688758)两日获机构大宗交易净买入超789万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611145861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611145861?lang=zh_cn&edition=full","pubTime":"2026-02-15 01:50","pubTimestamp":1771091422,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘,赛分科技报收于20.27元,较上周的18.88元上涨7.36%。本周,赛分科技2月11日盘中最高价报20.7元。本周关注点来自交易信息汇总:2月11日至12日,赛分科技连续两日共发生2笔大宗交易,机构合计净买入789.4万元。2月11日,赛分科技发生1笔大宗交易,机构净买入394.2万元。期间股价上涨0.37%,截至2月9日收盘价为19.19元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2610148949","title":"2月12日赛分科技现1笔大宗交易 机构净买入395.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610148949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610148949?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:42","pubTimestamp":1770889342,"startTime":"0","endTime":"0","summary":"证券之星消息,2月12日赛分科技发生大宗交易,交易数据如下:大宗交易成交价格19.76元,相对当日收盘价折价0.7%,成交20万股,成交金额395.2万元,买方营业部为机构专用,卖方营业部为国泰海通证券股份有限公司上海黄浦区福州路证券营业部。近三个月该股共发生2笔大宗交易,合计成交4000.0手,折价成交2笔。截至2026年2月12日收盘,赛分科技报收于19.9元,上涨0.25%,换手率1.74%,成交量5.2万手,成交额1.03亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200029014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2610980764","title":"2月11日赛分科技现1笔大宗交易 机构净买入394.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610980764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610980764?lang=zh_cn&edition=full","pubTime":"2026-02-11 17:30","pubTimestamp":1770802206,"startTime":"0","endTime":"0","summary":"证券之星消息,2月11日赛分科技发生大宗交易,交易数据如下:大宗交易成交价格19.71元,相对当日收盘价折价0.71%,成交20万股,成交金额394.2万元,买方营业部为机构专用,卖方营业部为国泰海通证券股份有限公司上海黄浦区福州路证券营业部。近三个月该股共发生1笔大宗交易,合计成交2000.0手,折价成交1笔。截至2026年2月11日收盘,赛分科技报收于19.85元,上涨3.17%,换手率2.81%,成交量8.39万手,成交额1.68亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100027842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2610648914","title":"2月10日赛分科技发布公告,股东减持101.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610648914","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610648914?lang=zh_cn&edition=full","pubTime":"2026-02-10 17:22","pubTimestamp":1770715377,"startTime":"0","endTime":"0","summary":"证券之星消息,2月10日赛分科技发布公告《赛分科技:苏州赛分科技股份有限公司简式权益变动报告书》,其股东南京华泰大健康一号股权投资合伙企业(有限合伙)、南京华泰大健康二号股权投资合伙企业(有限合伙)于2026年2月4日至2026年2月9日间合计减持101.16万股,占公司目前总股本的0.2429%,变动期间该股股价上涨0.37%,截止2月9日收盘报19.19元。股东增减持详情见下表:根据赛分科技2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000027855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2610612677","title":"赛分科技(688758.SH):财务总监卞庆莲辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2610612677","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610612677?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:07","pubTimestamp":1770710822,"startTime":"0","endTime":"0","summary":"格隆汇2月10日丨赛分科技公布,公司于近日收到公司财务总监卞庆莲女士的书面辞任报告,卞庆莲女士因职务调整,申请辞去公司财务总监即财务负责人的职务,辞任后继续在公司担任财务高级经理职务。 公司于2026年2月9日召开第二届董事会2026年第一次会议,审议通过《关于聘任公司副总经理的议案》,经董事会提名委员会审查,董事会同意聘任孙克先生为公司副总经理,任期自本次董事会审议通过之日起至第二届董事会届满之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260210/32009876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2604925595","title":"每周股票复盘:赛分科技(688758)股东拟合计减持不超6%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925595","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925595?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:50","pubTimestamp":1768679417,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,赛分科技报收于19.4元,较上周的18.39元上涨5.49%。本周,赛分科技1月16日盘中最高价报19.68元。大健康一号、大健康二号及道兴投资亦计划合计减持不超过公司总股本3%的股份,方式及期间相同。上述股东已作出股份锁定及减持承诺,本次减持计划与其一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2602175595","title":"赛分科技(688758.SH)股东拟合计减持不超6%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2602175595","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602175595?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:40","pubTimestamp":1768221646,"startTime":"0","endTime":"0","summary":"智通财经APP讯,赛分科技(688758.SH)发布公告,同华高新长期看好公司的发展,因其资金安排原因,计划通过集中竞价和大宗交易的方式减持其所持有的公司股份不超过1249.39万股,减持比例不超过公司总股本的3%。大健康一号、大健康二号及道兴投资长期看好公司的发展,因其资金安排原因,计划通过集中竞价和大宗交易的方式减持其所持有的公司股份不超过1249.39万股,减持比例不超过公司总股本的3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2602256521","title":"赛分科技(688758)2.56亿股限售股将于1月12日解禁,占总股本61.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602256521","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602256521?lang=zh_cn&edition=full","pubTime":"2026-01-12 08:02","pubTimestamp":1768176142,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,赛分科技于1月12日将有2.56亿股限售股份解禁,为公司首发原股东限售股份,首发战略配售股份,占公司总股本61.4%。最近一年内,该股累计解禁297.5万股,占总股本的0.71%。本次解禁后,公司还有1.18亿股限售股份,占总股本28.4%。赛分科技主营业务:致力于研发和生产用于药物分析检测和分离纯化的液相色谱材料,是集研发、生产与全球销售于一体的高新技术企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2600091036","title":"每周股票复盘:赛分科技(688758)61.40%限售股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2600091036","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600091036?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:37","pubTimestamp":1767296230,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,赛分科技报收于18.16元,较上周的18.42元下跌1.41%。本周,赛分科技12月22日盘中最高价报18.57元。12月23日盘中最低价报17.87元。赛分科技当前最新总市值73.84亿元,在化学制药板块市值排名78/150,在两市A股市值排名2498/5181。其中战略配售限售股4,997,569股,首发限售股250,706,767股,对应股东共30名,锁定期均为12个月。本次上市流通后,相关股东剩余限售股数量为零。保荐人中信证券对本次限售股上市流通无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2595673650","title":"赛分科技(688758)披露首次公开发行部分限售股及部分战略配售限售股上市流通公告,12月29日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673650","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673650?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:39","pubTimestamp":1767019156,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘,赛分科技报收于17.93元,较前一交易日下跌1.27%,最新总市值为74.67亿元。该股当日开盘18.21元,最高18.23元,最低17.9元,成交额达2637.27万元,换手率为3.44%。近日,苏州赛分科技股份有限公司发布首次公开发行部分限售股及部分战略配售限售股上市流通公告。其中,战略配售限售股为4,997,569股,限售期为12个月;首发限售股为250,706,767股,涉及股东29名,锁定期均为12个月。本次上市流通后,相关股东剩余限售股数量为零。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2591695615","title":"12月15日赛分科技跌5.05%,广发中证A500ETF联接A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591695615","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591695615?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:36","pubTimestamp":1765784182,"startTime":"0","endTime":"0","summary":"证券之星消息,12月15日赛分科技跌5.05%,收盘报18.6元,换手率5.79%,成交量2.46万手,成交额4655.15万元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为广发基金的广发中证A500ETF联接A。广发中证A500ETF联接A目前规模为33.21亿元,最新净值1.1529,较上一交易日上涨0.75%,近一年上涨17.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500012997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["560510","688758","BK0229"],"gpt_icon":0},{"id":"2583651866","title":"每周股票复盘:赛分科技(688758)抗体领域收入占工业纯化六成","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651866","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651866?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:11","pubTimestamp":1763233870,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,赛分科技报收于22.68元,较上周的19.43元上涨16.73%。本周,赛分科技11月14日盘中最高价报23.4元。前三季度,抗体领域收入1.26亿元,同比增长129.40%,占工业纯化总收入的60.62%。重组蛋白领域收入330.19万元,同比下降,主因客户管线处于临床III期,尚未复购。其他领域收入495.60万元,与去年同期基本持平。第三季度新增项目75个,其中研发阶段57个,临床阶段14个,商业化阶段4个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2583552889","title":"11月13日赛分科技涨10.92%,广发中证A500ETF联接A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583552889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583552889?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:29","pubTimestamp":1763022563,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日赛分科技涨10.92%创60日新高,收盘报22.14元,换手率21.43%,成交量9.1万手,成交额1.95亿元。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为广发基金的广发中证A500ETF联接A。广发中证A500ETF联接A目前规模为33.21亿元,最新净值1.1619,较上一交易日下跌0.23%,近一年上涨15.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["560510","BK0229","688758"],"gpt_icon":0},{"id":"2582316442","title":"【机构调研记录】同泰基金调研赛分科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316442?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:04","pubTimestamp":1762905895,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月11日披露的机构调研信息,同泰基金近期对1家上市公司进行了调研,相关名单如下:1)赛分科技 调研纪要:前三季度,抗体领域收入占比60.62%,胰岛素/多肽/GLP-1占比35.41%。第三季度新增项目75个,累计达1,126个。同泰基金成立于2018年,截至目前,资产管理规模47.28亿元,排名156/211;资产管理规模47.26亿元,排名136/211;管理公募基金数48只,排名107/211;旗下公募基金经理6人,排名135/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200005020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2582316177","title":"【机构调研记录】交银施罗德基金调研慧翰股份、赛分科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316177?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:04","pubTimestamp":1762905887,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月11日披露的机构调研信息,交银施罗德基金近期对2家上市公司进行了调研,相关名单如下:1)慧翰股份 调研纪要:公司已于2025年9月30日通过国标ECS测试,成为全球首家通过该认证企业,产品兼容全球紧急呼叫系统。eCall系统因关乎生命安全,需通过多项严苛测试,公司技术标准高于行业要求。2)赛分科技 调研纪要:前三季度,抗体领域收入占比60.62%,胰岛素/多肽/GLP-1占比35.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200005008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301600","BK0229","688758","BK0214"],"gpt_icon":0},{"id":"2582316417","title":"【私募调研记录】天虫资本调研赛分科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316417?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:04","pubTimestamp":1762905878,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月11日披露的机构调研信息,知名私募天虫资本近期对1家上市公司进行了调研,相关名单如下:1)赛分科技 调研纪要:前三季度,抗体领域收入占比60.62%,胰岛素/多肽/GLP-1占比35.41%。商业化阶段收入占近60%,临床III期占19%。第三季度新增项目75个,累计达1,126个。临床I期与II期需求稳定增长。海外市场收入同比增长超3倍,公司布局美国工厂。GLP-1领域合作覆盖率高。大分子药物商业化订单金额更高,复购周期1-2年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025111200004996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2582631647","title":"【私募调研记录】信复创值调研赛分科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2582631647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582631647?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:04","pubTimestamp":1762905876,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月11日披露的机构调研信息,知名私募信复创值近期对1家上市公司进行了调研,相关名单如下:1)赛分科技 调研纪要:前三季度,抗体领域收入占比60.62%,胰岛素/多肽/GLP-1占比35.41%。商业化阶段收入占近60%,临床III期占19%。第三季度新增项目75个,累计达1,126个。GLP-1领域合作覆盖率高。我们秉承\"践行诚信,复利增长,创造价值\"的投资、经营理念,付出最大努力为投资人,为股东,为社会,为家庭创造价值,积累财富。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025111200004991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688758","BK0229"],"gpt_icon":0},{"id":"2582316409","title":"【私募调研记录】翼虎投资调研赛分科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582316409?lang=zh_cn&edition=full","pubTime":"2025-11-12 08:04","pubTimestamp":1762905875,"startTime":"0","endTime":"0","summary":"根据市场公开信息及11月11日披露的机构调研信息,知名私募翼虎投资近期对1家上市公司进行了调研,相关名单如下:1)赛分科技 调研纪要:前三季度,抗体领域收入占比60.62%,胰岛素/多肽/GLP-1占比35.41%。第三季度新增项目75个,累计达1,126个。GLP-1领域合作覆盖率高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025111200004990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688758"],"gpt_icon":0},{"id":"2582811607","title":"【机构调研记录】民生加银基金调研赛分科技、欧陆通","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582811607?lang=zh_cn&edition=full","pubTime":"2025-11-10 08:01","pubTimestamp":1762732907,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月7日披露的机构调研信息,民生加银基金近期对2家上市公司进行了调研,相关名单如下:1)赛分科技 调研纪要:公司多数临床三期及商业化项目源于国产化替代场景,包括与复宏汉霖、信达生物等大客户合作。民生加银基金成立于2008年,截至目前,资产管理规模1685.19亿元,排名43/211;资产管理规模1343.14亿元,排名39/211;管理公募基金数177只,排名43/211;旗下公募基金经理28人,排名48/211。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000001557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0214","BK0229","300870","688758"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772229453571,"stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":0.0714},{"period":"3month","weight":-0.0633},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.1279},{"period":"ytd","weight":0.1342}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0028},{"period":"3month","weight":0.0705},{"period":"6month","weight":0.079},{"period":"1year","weight":0.2287},{"period":"ytd","weight":0.0489}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"苏州赛分科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"7159人(较上一季度减少31.51%)","perCapita":"41651股","listingDate":"2025-01-10","address":"江苏省苏州市吴中区中国(江苏)自由贸易试验区苏州片区苏州工业园区集贤街11号","registeredCapital":"41646万元","survey":" 苏州赛分科技股份有限公司的主营业务是研发和生产用于生物大分子等药物分析检测和分离纯化的液相色谱材料。公司主要产品为分析色谱柱、分析色谱填料、层析介质、预装柱,提供从药品研发、临床前(Pre-IND)到临床Ⅰ、Ⅱ、Ⅲ期、生产以及质控全周期全流程的分离纯化产品及相关服务。公司是集研发、生产与全球销售于一体的高新技术企业,荣获国家级专精特新“小巨人”企业等荣誉称号。","listedPrice":4.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛分科技(688758)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛分科技(688758)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛分科技,688758,赛分科技股票,赛分科技股票老虎,赛分科技股票老虎国际,赛分科技行情,赛分科技股票行情,赛分科技股价,赛分科技股市,赛分科技股票价格,赛分科技股票交易,赛分科技股票购买,赛分科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛分科技(688758)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛分科技(688758)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}